Comments
The board of Granules India on Thursday approved an investment of up to ₹20 crore in GIL Lifesciences Pvt Ltd, a wholly owned Indian subsidiary of the company. The board also gave the nod for issue of 1.865 crore warrants on preferential basis to Tyche Technologies Pvt Ltd, a promoter group company, subject to approval from the members. The company has called for an EGM on August 24 to consider the issue of warrants. The stock of Granules India surged 4.9 per cent at ₹102.45 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.